Cargando…

Visualization of the Effect of Assay Size on the Error Profile of Tumor Mutational Burden Measurement

Tumor mutational burden (TMB) refers to the number of somatic mutations in a tumor per megabase and is a biomarker for response to immune checkpoint inhibitor therapy. Immune checkpoint inhibitors are currently approved for tumors with TMB greater than or equal to 10 mutations/megabase. Many laborat...

Descripción completa

Detalles Bibliográficos
Autor principal: Bailey, Nathanael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949329/
https://www.ncbi.nlm.nih.gov/pubmed/35327986
http://dx.doi.org/10.3390/genes13030432